DayTwo is a start-up that provides personalized nutrition recommendations, which help balance individual blood sugar levels. In the following article, DayTwo Co-Founder and CEO Lihi Segal discusses the importance of health-tech and how the company copes with the current pandemic crisis. She also recalls meeting Weizmann Institute researchers Prof. Eran Segal and Prof. Eran Elinav – whose groundbreaking research serves as the company's IP backbone – and talks about how the successful collaboration between industry and academic research has generated a sustainable win-win scenario.  

Phytolon has been selected by EIT Food to receive a share of €5.4 million in new funding.

The COVID-19 Bridge Fund supports #agrifood #startups at the forefront of European food innovation

Read more about the announcement here: https://lnkd.in/dbD9qjP

Phytolon (€393.6K, IL) uses an environmentally friendly fermentation-based technology to produce natural food colours that are GMO-free, high-quality and sustainable

Internal Differences: A New Method for Seeing into Cells

The new technology may help answer outstanding questions about the immune system, cancer, Alzheimer’s, and more.

As the new CEO of EcoPhage, Orly Savion is writing a new and exciting chapter in her already-impressive professional career. She is also continuing her strong affiliation with the Weizmann Institute of Science and YEDA, the Institute's commercialization arm.

Top Influencers of Maariv - 25th Place (Hebrew)

The new partnership between Impact NRS LLC, a leading company operating in the field of health, wellness and sustainable development innovation, and YEDA, the commercial arm of the Weizmann Institute of Science, has led to the establishment of Plantae Biosciences LTD, a company dedicated to developing food technology solutions that are geared to impact global nutrition and environmental security.

An interview with the CEO of Yeda, Dr. Opher Shapira, who took office in the midst of a pandemic and radical changes in the global economy

“The pioneering idea of Yeda Research and Development – to commercialize the ideas of the Institute’s scientists – was groundbreaking at the time, and it has proven itself over the years. Its major successes in pharmaceuticals have been impressive, but the world outside the academic one has changed greatly. That is why the Yeda model also needs to be updated.”

The clever addition of lipids to water-based hydrogels makes them excellent lubricants for biomedical uses. What copes with heavy pressure and exists in a state of constant friction, decade after decade, yet barely gets worn down? The answer is the cartilage padding our joints – actually a marvelous system that both absorbs shocks and lubricates the joints, allowing bones to slide easily against one another.

he Hunger Games: Uncovering the Secret of the Hunger Switch in the Brain. Why are some people always hungry, no matter how much they eat? Hadar Israeli, Dr. Moran Shalev-Benami and Dr. Oksana Degtjarik from the Weizmann Institute of Science's Chemical and Structural Biology Department have uncovered how the brain's master switch for hunger actually works. 

BiomX: Rapidly Advancing Phage Therapeutics With Multiple Upcoming Catalysts. Yeda has licensed to BiomX a patent family with claims relating to "pharmaceutical composition and formulations, combinations of bacteriophage useful to treat acne, methods of use for these bacteriophage combinations, and methods of identifying patients who will respond to these bacteriophage combinations."